Genome-Based Drug Markets in China

Genome-Based Drug Markets in China

Category : Pharmaceuticals
March  2017  Pages : 240



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
China's demand for Genome-Based Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2006, 2011 and 2016) and long-term forecasts through 2021 and 2026 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.
TABLE OF CONTENTS



I. INTRODUCTION

Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT

Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. GENOME-BASED DRUG INDUSTRY ASSESSMENTS

Genome-Based Drug Industry Structure
Market Size
Market Growth Drivers
Major Producer Facility Locations and Output
Market Share of Key Producers
Labor Costs
Potential Entrants
Major Foreign Investments
Technology Development


IV. GENOME-BASED DRUG SALES VOLUMES AND FORECASTS

Overview
Genome-Based Drug Sales Volumes and Forecasts (Yuan)
Cytokines Drug
Peptide Hormones Drug
Thrombolytic Agents
Enzyme Drug
Soluble Recepter
Adhesion Molecule
Nucleic Acid Drug
Other Genome-Based Drug
Genome-Based Drug Imports and Exports
Pricing Trends


V. GENOME-BASED DRUG MARKET OUTLOOKS

Genome-Based Drug Markets Outlook Overview
Government Regulations
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Genome-Based Drug Sales by Region
East
North
Central
South
West


VI. MARKETING STRATEGIES

Distribution System in China
China's Distribution System
Genome-Based Drug Distribution Channels
Transportation and Freight Infrastructure
Communications
China’s Market Entry
Licensing
Franchising
E-commerce
Trading Companies and Local Agents
Representative Offices and Chinese Subsidiaries
Wholly Foreign Owned Enterprises

VII. GENOME-BASED DRUG PRODUCER DIRECTORY

Genome-Based Drug Producer Profiles
Distributors and Trading Companies
Research Institutions and Associations



LIST OF TABLES


I. INTRODUCTION

Economic Outlook Summary
Genome-Based Drug Supply and Demand Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade
Key Commodity Exports from China
China’s Exports to its Leading Trade Partners
Key Commodity Imports into China
China’s Imports from Its Leading Trade Partners

III. GENOME-BASED DRUG INDUSTRY ASSESSMENTS

Major Producer Facility Locations
Major Genome-Based Drug Producer Output
Market Share of Key Producers
Major Foreign Investments

IV. GENOME-BASED DRUG SALES VOLUMES AND FORECASTS

Overview
Genome-Based Drug Sales Volumes and forecasts (Yuan)
Cytokines Drug
Peptide Hormones Drug
Thrombolytic Agents
Enzyme Drug
Soluble Recepter
Adhesion Molecule
Nucleic Acid Drug
Other Genome-Based Drug
Genome-Based Drug Imports and Exports
Pricing Trends


V. GENOME-BASED DRUG Y MARKET OUTLOOKS

Total Genome-Based Drug Consumption by Market
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Genome-Based Drug Sales by Region
Northeast
North
Southeast
Central
Southwest
Northwest



LIST OF CHARTS


I. INTRODUCTION

Economic Outlook Summary
Genome-Based Drug Supply and Demand Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade
Key Commodity Exports from China
China’s Exports to its Leading Trade Partners
Key Commodity Imports into China
China’s Imports from Its Leading Trade Partners

III. GENOME-BASED DRUG INDUSTRY ASSESSMENTS

Major Producer Facility Locations
Major Genome-Based Drug Producer Output
Market Share of Key Producers
Major Foreign Investments

IV. GENOME-BASED DRUG SALES VOLUMES AND FORECASTS

Overview
Genome-Based Drug Sales Volumes and forecasts (Yuan)
Cytokines Drug
Peptide Hormones Drug
Thrombolytic Agents
Enzyme Drug
Soluble Recepter
Adhesion Molecule
Nucleic Acid Drug
Other Genome-Based Drug
Genome-Based Drug Imports and Exports
Pricing Trends


V. GENOME-BASED DRUG Y MARKET OUTLOOKS

Total Genome-Based Drug Consumption by Market
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Genome-Based Drug Sales by Region
Northeast
North
Southeast
Central
Southwest
Northwest

Enquiry Before Buy